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diabetes cases with an incidence rate of 1.05 per 100 person years. At
baseline, the mean age of OA patients was 61 years and 60% were
women. OA showed statistically signiﬁcant interactions with age and
gender. Both univariable and multivariable Cox PH models were ﬁtted
separately for men and women aged 20-64 and 65+ years. Unadjusted
and adjusted HRs (95% CI) for diabetes were 1.34 (1.24-1.45) and 1.15
(1.06-1.25), respectively, among menwith OA aged 20-64 years. Among
women with OA aged 20-64 years, unadjusted and adjusted HRs (95%
CI) for diabetes were 1.56 (1.45-1.69) and 1.20 (1.11-1.30), respectively.
Adjusted HRs for men and women with OA aged 65+ years were 0.91Obesity Phenotypes and Symptoms, Function and Knee OA
Outcomes Normal Weight
BMI<25 Met
Normal N¼640
Normal Weight
Met Abnormal
N¼493
Overweight BMI
25-29.9 Met
Normal N¼723
Overweight Met
Abnormal N¼1109
Obese BMI>¼30 Met
Normal N¼475
Obese Met
Abnormal
N¼1229
P value for Met
abnormal vs
normal
P for Trend
Mean Age 58.2 65.4 57.9 64.6 56.5 61.7 <0.001 0.17
Gender %women 70 68 54 49 61 58 <0.001 <0.001
Race %African American 5.5 8.2 10.4 16.1 20.9 29.1 <0.001 <0.001
K-L Grade (%)
0-1
2
3-4
75.5
17.7
6.7
67.6
19.4
12.9
61.9
24.4
13.7
54.7
25.7
19.6
51.9
31
17
41.6
34
24
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
WOMAC
Scores
Disability
PainStiffness
4.08
1.33
1.02
5.68
1.67
1.13
5.74
1.91
1.27
7.7
2.32
1.44
8.99
2.67
1.67
11.11
3.17
1.87
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
MSK Symptoms (%)
Back
Hand/Wrist
Shoulder
36.8
61.6
13.4
43.3
75.4
12.8
39.8
54.1
14.2
46.2
66.3
17.6
44.9
52.9
14.2
52.5
64.7
20.3
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
Hand Bumps (%)
Either Hand
41.2 64.9 35.7 48.7 28.4 43.5 <0.001 <0.001(0.81-1.02) and 0.99 (0.90-1.08), respectively which were not signiﬁ-
cantly different from 1.0.
Conclusion: This study suggests that younger men and womenwith OA
had increased risks of developing diabetes compared to their age and
sex matched counterparts. Further studies are needed to conﬁrm our
results in other populations and to elucidate the potential biological
mechanisms for this increased risk.
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CROSS-SECTIONAL RELATIONSHIP OF OBESITY METABOLIC
PHENOTYPES, MUSCULOSKELETAL SYMPTOMS, WOMAC SCORES
AND KNEE OA: A REPORT FROM OAI
C.B. Eaton y, M. Roberts z, M. Waring x, K. Lapane x, S. Yang k, S. Yang k,
J. Driban {, T. McAlindon #. yWarren Alpert Med. Sch. of Brown Univ.,
Pawtucket, RI; zMem. Hosp. of Rhode Island, Pawtucket, RI; xUniv. of
Massachusetts Med. Sch., Worster, MA; kVirginia Commonwealth Univ.,
Richmond, VA; { Tufts New England Med. Ctr., Boston, MA; # Tuft New
England Med. Ctr., Boston, MA
Purpose: The potential role of metabolic perturbations associated with
overweight and obesity and musculoskeletal symptoms, and knee
osteoarthritis is under researched. We hypothesized that overweight
and obese individuals with metabolic perturbations would have greater
musculoskeletal symptoms, worse WOMAC pain,stiffness and disability
scores and greater prevalence and severity of knee osteoarthritis.
Methods: The OAI is a multi-center prospective study of persons with
or at higher risk of knee OA aged between 45-79. Participants in the
Osteoarthritis Initiative at baseline had knee x-rays with KL grading,
WOMAC pain , stiffness and disability assessed, BMI determined, waist
circumference measured, and self report of presence of symptoms in
the back, shoulders, hand/wrist, and hand bumps determined. Meta-
bolic abnormalities were deﬁne by the presence of either hypertension,
hyperlipidemia or diabetes mellitus deﬁned by self-report or use of
medications. Overweight was deﬁned as BMI 25-29.9 kg/m2 and
Obesity as BMI >¼ 30 kg/m2.
Results: 4509 individuals were included in this analysis. The prevalence
of knee osteoarthritis, severity of knee OA, womac pain, stiffness and
disability scores and frequency of back pain, hand/wrist pain, shoulder
pain, and hand bumps were increased by obesity metabolic phenotypein a monotonically increasing manner across weight categories and
within each category when metabolically abnormalities were found
(p<0.001) see table
Conclusions: Compared to normal weight, metabolically benign indi-
viduals increasing adiposity and metabolic abnormalities are syner-
gistically associated with worse patient centered outcomes of
increasing knee speciﬁc pain, stiffness and disability, frequency of pain
in variety of other joints , most notably the hand and wrist, and higher
prevalence and severity of knee OA. Further studies explorating the
mechanisms of these associations and prospective associations are
warranted300
INFORMATION NEEDS REGARDING TOTAL JOINT ARTHROPLASTY
DIFFER BY GENDER
G.A. Hawker y, Y. Qi y, R. Saini z, W. Lou y, I. Stanaitis z, E. Badley y,
C. Borkhoff x, A. Davis y, S. Dunn y, M. Gignac y, S. Jaglal y, H. Kreder y, J.
Sale y. yUniv. of Toronto, Toronto, ON, Canada; zWomen's Coll. Hosp.,
Toronto, ON, Canada; xWomen's Collge Hosp., Toronto, ON, Canada
Purpose: When medical management of hip/knee arthritis fails, total
joint arthroplasty (TJA) is recommended. However, up to one-third of
potential TJA candidates are unwilling to consider this surgery. A
number of factors have been identiﬁed as contributing to unwillingness
but no study has evaluated the relative importance of these factors,
including whether importance ratings differ by gender. Our study
evaluated the relative importance of previously identiﬁed correlates of
TJA willingness overall and by gender.
Methods: In a cohort with hip/knee OA aged 50+ years, structured inter-
views were conducted in those who met criteria as ‘potential TJA candi-
dates’ (WOMAC30/96; no surgical contraindications) and indicated
being unsure or unwilling to consider TJA. Those with a prior TJA or on
a TJA wait list were excluded. Participants provided information on:
demographics; concurrent health problems; general health status; and
arthritis severity (WOMAC). For each of 18 items (e.g., length of recovery),
participants rated the importance of the item from ‘not at all important’ to
‘extremely important’ in TJA decision making. Item responses were sub-
jected to exploratory factoranalysis. Theprinciple factormethodwasused
to extract the factors, followed by a promax (oblique) rotation. Partici-
pants’ factor scores were estimated by summing the item scores multi-
plied by the factor loadings across all items. Multivariable logistic
regression model was used to evaluate the relationship between unwill-
ingness to considerTJA (deﬁnitelynotwillingversusprobablyunwillingor
unsure) and factor scores.Multiple linear regressionmodelingwasused to
study the relationship between factor scores and gender, controlling for
age (50-64, 65-74, 75+ years) and education (<high school,high school).
Results: 631 individuals with hip/knee OA participated (mean age 70
years, 78% female, 54% high school education). Factor analysis iden-
tiﬁed 4 factors: TJA risks/beneﬁts (5 items - risk of complications, pain
early and late post-surgery, function post-surgery, surgery may not
help); TJA indications (4 items: age - too old/too young; age - might
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S160need revision later; overall health); support during recovery (3 items:
length of recovery; doctors’ recommendations; availability of
resources); and others’ opinions (3 items: surgery as last resort;
friends’/family's recommendations; considerations about others).
Controlling for age and education, results from the multiple linear
regression model suggested that women rated risks/beneﬁts (p¼0.01),
indications (p¼0.02), and support during recovery (p¼0.002) as more
important in TJA decision making than did men, but rated ‘others’
opinions’ similarly (p¼0.35).
Conclusions: Our results identiﬁed the importance of information about
TJA in four distinct domains: indications for TJA, risks and beneﬁts of
surgery, support during recovery, and others’ opinions. Further, our
ﬁndings indicate that, after controlling for age and level of education,
gender differences exist in TJA information needs. These ﬁndings will be
useful to inform TJA education and patient-physician decision making.
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USE OF DRUG COMBINATIONS IN PATIENTS WITH OSTEOARTHRITIS:
A POPULATION-BASED COHORT STUDY
D. Prieto-Alhambra y,z, N. Wilson x. yBotnar Res. Ctr., Univ. of Oxford,
Oxford, United Kingdom; zMRC Lifecourse Epidemiology Unit, Univ. of
Southampton, Southampton, United Kingdom; x Inst. of Bone and Joint
Res., Kolling Inst. of Med. Res., Royal North Shore Hosp., Sydney, Australia
Purpose: Patients affected with osteoarthritis (OA) use different drugs
in search for relief, with potential impact on patients’ safety and
healthcare costs. However, the use of drug combinations in these
patients has not been explored in detail.
We used a large database including primary care medical records and
pharmacy invoice data to explore use of the following drugs in OA
patients in the period 2006-2010: non-steroidal anti-inﬂammatory
drugs (NSAIDs), Symptomatic Slow Acting Drugs for OA (SYSADOA),
COX-2 inhibitors (COX2i), opioids, and other analgesics (paracetamol
and metamizol).
Methods: - Study population and setting: We screened the SIDIAP
Database (www.sidiap.org) to identify those aged 40 years or older with
a new diagnosis of OA using ICD-10 codes. Among these, we ascertained
prevalence of use of oral NSAIDs, COX2i, SYSADOA, opioids, and anal-
gesics (all alone and in combination) in the period 2006-2011.
- Source of data: SIDIAP contains anonymised medical records
and pharmacy invoice data of a representative >5 million
people in Catalonia (North-East Spain).
- Statistical analyses: We estimated prevalence (and 99% Conﬁ-
dence Intervals) of use of these drugs and their combinations,
and the proportion of occasional (MPR25%) and regular
(MPR50%) users for each of them.
Results: We identiﬁed 281,356 patients with an incident clinical diag-
nosis of OA. Among these, 128,314(45.6%) were treated with 3 or more
drugs, and 57,835(20.6%) with no subsidized drugs.
The 3 most common combinations of drugs were: oral NSAID+analgesic
(12.2%); 2.topical NSAID+analgesic (2.5%); and oral NSAID+SYSADOA
(1.8%). Besides, 34,672(12.3%) patients received only 1 drug, the 3 most
common being, in descending order: oral NSAID, analgesic and SYSADOA.
The proportions of occasional and regular users were highest for SYSA-
DOA (24.5% occasional and 6.9% regular users), and lowest for opioidsĂ(7.3% occasional and 1.9% regular users). Proportions (%) of occasional
and regular users for each drug of study are presented in Figure.
Conclusions: About 75% of OA patients are treated with at least 2 drugs,
and more than half receive 3 or more. However, compliance with these
drugs is very low, and hence consequences of polymedication on
effectiveness and safety are difﬁcult to predict as based on clinical trials
results.
These data are of interest for health care provision for patients with OA.
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THE CONSULTATION PREVALENCE OF OSTEOARTHRITIS 2030 MAY
INCREASE BY 50%: PROGNOSIS FOR SWEDEN
A. Turkiewicz y, I.F. Petersson y, J. Björk z, L.E. Dahlberg y, M.
Englund y,x. yDept. of Orthopedics, Clinical Sci. Lund, Lund, Sweden;
zDiv. of Occupational and Environmental Med., Lund Univ., Lund,
Sweden; xClinical Epidemiology Res. and Training Unit, Boston Univ. Sch.
of Med., Boston, MA, USA
Purpose: To project the future consultation prevalence of osteoarthritis
(OA) in the knee, hip and hand.
Methods: The Skåne Health Care Register (SHCR) is a legislative,
mandatory register in Skåne County, Sweden (total population 1.3
million), based on physicians’ International Classiﬁcation of Diseases
(ICD) 10 diagnostic codes. We used observational data on the consul-
tation prevalence of the knee OA (M17), hip OA (M16) and hand/wrist
OA (M15.1, M15.2, M18, M19.0D, M19.1D, M19.2D) by the 31st Dec 2011Figure 1. The prognosis of OA consultation prevalence in knee, hip and hand in
Swedish adults (aged 20+).
